Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0T | 1.9T | 1.7T | 1.9T |
Cost of revenue | 1.7T | 1.7T | 1.6T | 1.7T |
Gross profit | 265.4B | 206.5B | 158.5B | 215.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 127.6B | 148.6B | 139.9B | 126.3B |
Operating income | 108.7B | 32.7B | -7.7B | 60.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 21.8B | 24.6B | 25.5B | 20.8B |
Other income expense | — | — | — | — |
Pretax income | 100.4B | 27.7B | -5.9B | 48.4B |
Tax provision | 16.8B | 6.2B | -1.4B | 11.2B |
Net income | 83.7B | 21.5B | -4.5B | 37.2B |
Basic EPS | — | 1.5 | -0.1 | 2.6 |
Diluted EPS | — | 1.5 | -0.1 | 2.6 |
Basic average shares | — | 13.7B | 14.1B | 13.8B |
Diluted average shares | — | 13.7B | 14.1B | 13.8B |
EBITDA | 123.9B | 45.3B | 6.3B | 71.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.4B | -320.6M | 2.8B | -1.9B |
Preferred stock dividends | 0 | 0 | 0 | 0 |